Available to sourceHuman Prescription DrugGastrointestinal

Potassium Acetate

3.93 g/20mL · Injection Solution Concentrate

By Fresenius Kabi USA, LLC

NDC: 65219-510
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative , Potassium Compounds [CS], Potassium Salt
Marketing category: ANDA

Package sizes

25 VIAL, SINGLE-DOSE in 1 TRAY (65219-510-20) / 20 mL in 1 VIAL, SINGLE-DOSE (65219-510-02)NDC 65219-510-20Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.